Velan Capital Investment Management
Latest statistics and disclosures from Velan Capital Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALIM, JSPR, PRAX, IWM, HRTX, and represent 71.42% of Velan Capital Investment Management's stock portfolio.
- Added to shares of these 10 stocks: JSPR (+$43M), PRAX (+$21M), IWM (+$21M), XBI (+$14M), TRML (+$7.3M), OTLK (+$6.0M), AQST, MIST, NVNO, Kiora Pharmaceuticals.
- Started 10 new stock positions in TRML, PRAX, OTLK, Kiora Pharmaceuticals, IWM, MIST, JSPR, NVNO, AQST, XBI.
- Reduced shares in these 10 stocks: Praxis Precision Medicines I (-$8.9M), Jasper Therapeutics (-$6.8M), QIPT (-$6.1M), LNTH (-$5.2M), MLTX, , GOSS, CABA, APLS, .
- Sold out of its positions in ANNX, APLS, CABA, CGEM, Edesa Biotech, GOSS, Icosavax, ImmunoGen, Inhibrx, IOVA. Jasper Therapeutics, LNTH, MLTX, Praxis Precision Medicines I, QIPT, THC, IFRX.
- Velan Capital Investment Management was a net buyer of stock by $69M.
- Velan Capital Investment Management has $221M in assets under management (AUM), dropping by 79.65%.
- Central Index Key (CIK): 0001848809
Tip: Access up to 7 years of quarterly data
Positions held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 21 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Alimera Sciences Com New (ALIM) | 24.0 | $53M | 14M | 3.90 |
|
|
Jasper Therapeutics Com New (JSPR) | 19.5 | $43M | NEW | 1.5M | 29.36 |
|
Praxis Precision Medicines I Com New (PRAX) | 9.7 | $21M | NEW | 351k | 61.02 |
|
Ishares Tr Russell 2000 Etf Put Option (IWM) | 9.5 | $21M | NEW | 100k | 210.30 |
|
Heron Therapeutics (HRTX) | 8.7 | $19M | 7.0M | 2.77 |
|
|
Spdr Ser Tr S&p Biotech Put Option (XBI) | 6.4 | $14M | NEW | 150k | 94.89 |
|
Adma Biologics (ADMA) | 4.6 | $10M | -11% | 1.5M | 6.60 |
|
Tourmaline Bio (TRML) | 3.3 | $7.3M | NEW | 319k | 22.90 |
|
Outlook Therapeutics (OTLK) | 2.7 | $6.0M | NEW | 500k | 11.94 |
|
Optinose (OPTN) | 2.0 | $4.4M | -16% | 3.0M | 1.46 |
|
Tela Bio (TELA) | 1.9 | $4.2M | 746k | 5.67 |
|
|
Inspire Med Sys (INSP) | 1.7 | $3.9M | +17% | 18k | 214.79 |
|
Aquestive Therapeutics (AQST) | 1.2 | $2.6M | NEW | 600k | 4.26 |
|
Elevation Oncology (ELEV) | 1.2 | $2.6M | 497k | 5.13 |
|
|
Inspiremd (NSPR) | 1.0 | $2.1M | 904k | 2.37 |
|
|
Geron Corporation (GERN) | 0.7 | $1.7M | -35% | 500k | 3.30 |
|
Milestone Pharmaceuticals (MIST) | 0.5 | $1.2M | NEW | 650k | 1.79 |
|
Rezolute Com New (RZLT) | 0.5 | $1.0M | 400k | 2.55 |
|
|
Envveno Medical (NVNO) | 0.4 | $937k | NEW | 172k | 5.44 |
|
Kiora Pharmaceuticals Com New | 0.4 | $777k | NEW | 1.1M | 0.71 |
|
Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.2 | $385k | 625k | 0.62 |
|
Past Filings by Velan Capital Investment Management
SEC 13F filings are viewable for Velan Capital Investment Management going back to 2021
- Velan Capital Investment Management 2024 Q1 filed May 14, 2024
- Velan Capital Investment Management 2023 Q3 filed Nov. 13, 2023
- Velan Capital Investment Management 2023 Q2 filed Aug. 11, 2023
- Velan Capital Investment Management 2023 Q1 filed May 15, 2023
- Velan Capital Investment Management 2022 Q4 filed Feb. 13, 2023
- Velan Capital Investment Management 2022 Q3 filed Nov. 14, 2022
- Velan Capital Investment Management 2022 Q2 filed Aug. 15, 2022
- Velan Capital Investment Management 2022 Q1 filed May 16, 2022
- Velan Capital Investment Management 2021 Q4 filed Feb. 14, 2022